Financials

  • Market Capitalization 5.56 M
  • Employee 3
  • Founded 2010
  • CEO N/A
  • Website www.silopharma.com
  • Headquarter Nevada, United States
  • FIGI BBG002D1DZ06
  • Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-0.05
Price to sales ratio
39.53

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
4940
APVO
Aptevo Therapeutics Inc. - Common Stock
4.62 USD+11.33%+1.99%-0.43%-31.56%5.76 M USD
4943
ADIL
Adial Pharmaceuticals, Inc - Common Stock
2.65 USD-6.36%-7.67%-5.36%+597.37%5.68 M USD
4950
SNGX
Soligenix, Inc. - Common Stock
0.37 USD+5.71%-2.63%-15.91%-67.26%5.48 M USD
4951
NCNA
NuCana plc - American Depositary Shares
1.31 USD+2.34%-6.43%-33.16%-39.07%5.45 M USD

Frequently asked questions about Silo Pharma Inc -, effectuated 1:50 R/S on 9/15

What is the Silo Pharma Inc -, effectuated 1:50 R/S on 9/15 stock price today?

The current price of Silo Pharma Inc -, effectuated 1:50 R/S on 9/15 (SILO) is 5.13. Over the past 24 hours, the stock has changed by -2.84%. Follow the SILO chart for real-time price dynamics.

What is the stock ticker of Silo Pharma Inc -, effectuated 1:50 R/S on 9/15?

Silo Pharma Inc -, effectuated 1:50 R/S on 9/15 trades under the ticker SILO. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Silo Pharma Inc -, effectuated 1:50 R/S on 9/15 stock going up?

SILO has changed by -11.25% over the last week, -19.97% over the last month, and +784.48% over the last year. Review the chart to see whether the current move is part of a broader trend.

What was Silo Pharma Inc -, effectuated 1:50 R/S on 9/15 net income for the last quarter?

Silo Pharma Inc -, effectuated 1:50 R/S on 9/15 reported net income of -1.65 M for the last quarter. The previous quarter showed -881.53 K, which means net income changed by -86.85%.

How many employees does Silo Pharma Inc -, effectuated 1:50 R/S on 9/15 have?

As of the latest available data, Silo Pharma Inc -, effectuated 1:50 R/S on 9/15 has 3 employees. Workforce size can provide additional context about the company's scale and operations.

What is Silo Pharma Inc -, effectuated 1:50 R/S on 9/15 EBITDA?

Silo Pharma Inc -, effectuated 1:50 R/S on 9/15 EBITDA is -1.59 M, and its EBITDA margin is -8 830.15%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

How can I buy Silo Pharma Inc -, effectuated 1:50 R/S on 9/15 stock?

You can buy Silo Pharma Inc -, effectuated 1:50 R/S on 9/15 (SILO) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Silo Pharma Inc -, effectuated 1:50 R/S on 9/15 stock?

Investing in Silo Pharma Inc -, effectuated 1:50 R/S on 9/15 requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the SILO chart and related analysis on metatrader.com as part of your research.

News